Brand name 20-day closing price ⇒ difference from the previous day
Kosel <6905> 1273 -93
Negative outlook on earnings for this term is causing further disappointment.
HU Group <4544> 2348.5 -123.5
Morgan Stanley MUFG Securities has downgraded their investment determination.
Akebono Brake Industry <7238> 166 -12
Akaushi Brake Industry <7238> is down 8 points to 170.
Tamahome <1419> 3860 -120
Although there was a sense of being unconvinced by the downward revision on the 19th.
Keisei Electric Railway <9009> 5165 -147
On the 19th, JP Morgan Securities downgraded its investment rating.
Hokkaido Electric Power <9509> 1324.5 -29.5
Fujikura <5803> fell below the 25-day moving average, leading to dominant short-covering sales.
Fujikura <5803> 3120 -73
Closed sell-off is dominant as it breaks through the 25-day line.
TradeWorks <3997> 963+150
Buying material in view of capital business tie-up with SCSK.
Kurogane Kosakusho <7997> 1327 +300
Although there was a sudden movement from the 19th, there was no material.
Cuschim <2345> 276 +21
Anticipation for overseas trade decision continues for "SNPIT Token".
Isehaka <4107> 21340 -3210
Philip Securities report on the 19th continues to sell off materials.
Tim's <4891> 223 +10
First administration of the phase 1 clinical trial candidate for acute kidney injury treatment.
Manabi Aid <184A> 965 -101
Profit-taking sales are dominant on a significant increase on the 19th.
AHC Group <7083> 2527 +500
Due to the light movement, short-term funds are heading towards it. 3rd day of stop rising in 20 days.
Green Ena <1436> 2200 -116
The year-to-date high was significantly higher on the 19th. Profit-taking selling is dominant on the 20th.
Helios <4593> 190 +30
Astellas Pharma <4503> signs a license agreement with a subsidiary.
Haifan <3133> 957 -41
75-day line acts as resistance level for upper price limits.
ELEMENTS <5246> 1215 +136
Driven by the momentum of the 19th stop rise, the year-to-date high.
Stella Pharma <4888> 368 -9
The upward momentum has weakened as it dropped below the 25-day moving average.
VIS <130A> 1080 -40
The first milestone was achieved in collaborative drug discovery research with Takeda Pharmaceutical <4502>.
Although it was initially bought up, it lost momentum.
Aiming <3911> 237 +2
Although it was sold on the 19th due to the dissolution of the joint venture of the smartphone game "STREAM HERO!", there will also be buy-on-dip on the 20th.
Gaming "STREAM HERO!" Joint venture dissolution sold on the 19th, but there will also be buying opportunities on the 20th.